With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications. More
Articles
Dear NVDA Stock Fans, Mark Your Calendars for Aug. 23
Although Nvidia has recently encountered some negative print in the chart, Morgan Stanley has pounded the table on NVDA stock. More
MULN Stock Alert: Mullen Posts Quarterly Loss of $11.14 a Share
MULN stock is in focus after the electric vehicle company reported its earnings for the three months ended June 30. More